Skip to content

Alpha Cognition ACOG Common stock, shares issued (in shares)

Common stock, shares issued (in shares) at other companies

AbbVie logo
AbbVieABBV
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI

Other financials

Income statement

See full
Revenue$3.5M+20.7%
Gross profit$3.3M+12.7%
Operating income-$8.1M-138%
Net income-$6.5M-276%
EPS (diluted)-$0.32-191%

Balance sheet

See full
Cash & equivalents$54.3M+100,638%
Total equity$57.5M+49.2%
Total assets$69.2M+42.5%

Cash flow

See full
Operating cash flow-$11.8M-477%
CapEx$1.3K-97.9%
Free cash flow-$11.8M-460%

Valuation

See full
Market cap$157.21M+6.6%
P/S14.5×

Profitability

See full
Gross margin89.3%
Operating margin-250.1%
Net margin-232.2%
FCF margin-280.5%

Returns & leverage

See full
Return on equity-52.4%-5.3pp
Current ratio12.6×-4.5×

Where this comes from

Reported directly by Alpha Cognition in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: Alpha Cognition’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alpha Cognition's common stock, shares issued (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alpha Cognition's common stock, shares issued (in shares)?
Alpha Cognition (ACOG) reported common stock, shares issued (in shares) of $21.77M in Q1 2026.
How has Alpha Cognition's common stock, shares issued (in shares) changed year-over-year?
Alpha Cognition's common stock, shares issued (in shares) increased by 35.9% year-over-year, from $16.02M to $21.77M.
What is the long-term trend for Alpha Cognition's common stock, shares issued (in shares)?
Over 2 years (2023 to 2025), Alpha Cognition's common stock, shares issued (in shares) has grown at a 114.4% compound annual growth rate (CAGR), from $4.73M to $21.74M.